I hear you, and I accept that, but I have to say that it's not much of an answer. I mean, really, what it suggests is that reports and concerns were going in, and they were either deemed to be not credible enough to act on or somebody still didn't act on information when they should have. At the end of the day, the Auditor General went in and found out that there wasn't proper compliance. There's some reporting going on. Somebody said, “We don't need to do anything”, and that's wrong. That's all I'm pointing out.
I want to ask about the chart on page 10 of the Auditor General's report, which points out the activities that are insufficient, and it is almost all of them. I'm wondering about products that are already out there now. I hear you have an action plan. I'm assuming we'll see that at some point, but I'd like to know about products that are out there now.
For instance, if I were thinking of conducting investigations of clinical trials, if there was insufficient activity being done to protect Canadians on that, it would mean there was a possibility that some drug products out there perhaps shouldn't be.
Could I have your thoughts on that, sir?